ACCUTOX Trademark

Trademark Overview

On Wednesday, July 7, 2021, a trademark application was filed for ACCUTOX with the United States Patent and Trademark Office. The USPTO has given the ACCUTOX trademark a serial number of 90816106. The federal status of this trademark filing is REVIVED - AWAITING FURTHER ACTION as of Wednesday, September 4, 2024. This trademark is owned by Innomed Technologies, Inc.. The ACCUTOX trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development services in the medical field, namely, in the field of injection devices; research and development of new products in the medical and surgical fields, namely, injectors, syringes and drug delivery devices and accessories for use with injectors, syringes and drug delivery devices; product design, development, and engineering in the medical and surgical fields; product development consultation in the field of technological and medical innovation; innovation consulting services, namely, advising others in the areas of product innovation and development for instruments, devices and apparatus for medical and surgical purposes, namely, injectors, syringes and drug delivery devices; research and development in the fields of neurotoxins, dermal fillers and other pharmaceuticals for medical and cosmetic surgery purposes; Scientific research in the nature of monitoring and conducting clinical trials for others, namely, pharmaceutical trials; testing of medical products, ...
accutox

General Information

Serial Number90816106
Word MarkACCUTOX
Filing DateWednesday, July 7, 2021
Status616 - REVIVED - AWAITING FURTHER ACTION
Status DateWednesday, September 4, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 25, 2023

Trademark Statements

Goods and ServicesResearch and development services in the medical field, namely, in the field of injection devices; research and development of new products in the medical and surgical fields, namely, injectors, syringes and drug delivery devices and accessories for use with injectors, syringes and drug delivery devices; product design, development, and engineering in the medical and surgical fields; product development consultation in the field of technological and medical innovation; innovation consulting services, namely, advising others in the areas of product innovation and development for instruments, devices and apparatus for medical and surgical purposes, namely, injectors, syringes and drug delivery devices; research and development in the fields of neurotoxins, dermal fillers and other pharmaceuticals for medical and cosmetic surgery purposes; Scientific research in the nature of monitoring and conducting clinical trials for others, namely, pharmaceutical trials; testing of medical products, namely, dermal fillers, neurotoxins, injectors, syringes and other drug delivery devices, particularly drug delivery devices for dermal fillers and neurotoxins

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, March 20, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameInnomed Technologies, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressEncino, CA 91436
Party NameInnomed Technologies, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressEncino, CA 91436

Trademark Events

Event DateEvent Description
Thursday, October 13, 2022ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Saturday, July 10, 2021NEW APPLICATION ENTERED
Wednesday, September 15, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, March 25, 2022ASSIGNED TO EXAMINER
Friday, April 1, 2022NON-FINAL ACTION WRITTEN
Friday, April 1, 2022NON-FINAL ACTION E-MAILED
Friday, April 1, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, October 13, 2022ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Thursday, October 13, 2022ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Wednesday, October 19, 2022TEAS PETITION TO REVIVE RECEIVED
Saturday, December 10, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 19, 2022PETITION TO REVIVE-GRANTED
Wednesday, October 19, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, October 20, 2022NOTICE OF REVIVAL - E-MAILED
Saturday, December 10, 2022ASSIGNED TO LIE
Saturday, December 10, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, December 16, 2022NON-FINAL ACTION WRITTEN
Friday, December 16, 2022NON-FINAL ACTION E-MAILED
Friday, December 16, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, March 16, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, March 16, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, March 17, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 20, 2023EXAMINERS AMENDMENT -WRITTEN
Monday, March 20, 2023EXAMINERS AMENDMENT E-MAILED
Monday, March 20, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, March 20, 2023EXAMINER'S AMENDMENT ENTERED
Wednesday, March 22, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 5, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 25, 2023PUBLISHED FOR OPPOSITION
Tuesday, April 25, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 19, 2023SOU EXTENSION 1 FILED
Tuesday, June 20, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 19, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, December 19, 2023SOU EXTENSION 1 GRANTED
Thursday, December 21, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 4, 2024NOTICE OF REVIVAL - E-MAILED
Wednesday, September 4, 2024PETITION TO REVIVE-GRANTED
Wednesday, September 4, 2024TEAS PETITION TO REVIVE RECEIVED
Wednesday, September 4, 2024SOU EXTENSION RECEIVED WITH TEAS PETITION
Monday, July 22, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, July 22, 2024ABANDONMENT - NO USE STATEMENT FILED

Related Keywords

accutox medical development namely devices research drug syringes product injectors delivery